Lansforsakringar Fondforvaltning AB publ acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 95,310 shares of the medical research company's stock, valued at approximately $12,804,000.
A number of other institutional investors have also recently made changes to their positions in the business. Sienna Gestion raised its stake in Agilent Technologies by 29.8% in the fourth quarter. Sienna Gestion now owns 78,445 shares of the medical research company's stock valued at $10,537,000 after buying an additional 17,991 shares during the last quarter. Sequoia Financial Advisors LLC increased its holdings in shares of Agilent Technologies by 8.5% during the fourth quarter. Sequoia Financial Advisors LLC now owns 33,898 shares of the medical research company's stock valued at $4,554,000 after acquiring an additional 2,664 shares in the last quarter. Prudential PLC raised its position in shares of Agilent Technologies by 16.0% in the 4th quarter. Prudential PLC now owns 73,273 shares of the medical research company's stock valued at $9,843,000 after purchasing an additional 10,128 shares during the last quarter. Commonwealth Equity Services LLC boosted its stake in Agilent Technologies by 9.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 43,862 shares of the medical research company's stock worth $5,892,000 after purchasing an additional 3,915 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in Agilent Technologies by 16.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 49,288 shares of the medical research company's stock worth $6,621,000 after purchasing an additional 6,802 shares in the last quarter.
Agilent Technologies Stock Performance
A stock traded down $1.45 during trading on Friday, hitting $111.83. 4,751,122 shares of the company traded hands, compared to its average volume of 1,944,688. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The stock's 50-day simple moving average is $108.61 and its 200 day simple moving average is $126.62. The company has a market cap of $31.88 billion, a PE ratio of 27.61, a P/E/G ratio of 3.13 and a beta of 1.27.
Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 26.13%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. During the same period in the previous year, the firm earned $1.22 EPS. The business's quarterly revenue was up 6.0% on a year-over-year basis. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.
Agilent Technologies Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.89%. Agilent Technologies's dividend payout ratio is currently 24.44%.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on the stock. TD Cowen upped their price target on shares of Agilent Technologies to $150.00 and gave the company a "buy" rating in a research note on Thursday. Jefferies Financial Group cut their target price on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Barclays reduced their target price on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Wells Fargo & Company dropped their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Finally, Robert W. Baird cut their price objective on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating on the stock in a report on Thursday, May 22nd. Seven research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and a consensus price target of $140.15.
Get Our Latest Stock Report on Agilent Technologies
Insider Transactions at Agilent Technologies
In related news, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares of the company's stock, valued at approximately $2,657,456.28. This represents a 8.05% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the completion of the sale, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. The trade was a 4.84% decrease in their position. The disclosure for this sale can be found here.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
